The detection of several molecular markers, including IDH1 mutation, 1p/19q codeletion, MGMT promoter methylation status has been applied with clinical diagnoses of gliomas (21, 22), we analyzed whether LMO1 expression was correlated with some molecular genetic characteristics by using CGGA database. The gene discussed is MGMT; the disease is central nervous system cancer.